Influence of thrombolytic therapy on the condition of matrix metalloproteinase and their inhibitors system in patients with Q-wave myocardial infarction
DOI:
https://doi.org/10.14739/2310-1210.2014.4.27219Keywords:
Myocardial Infarction, Matrix Metalloproteinase, Thrombolytic TherapyAbstract
Myocardial infarction (MI) is one of the most important problems of modern cardiology all over the world and, particularly, in Ukraine. Implementation of thrombolysis into the treatment leads to significant reduction of mortality from MI. Nowadays the most progressive treatment method is percutaneous coronary intervention. It was proved in several randomized controlled clinical trials (DANAMI-2, PRAGUE-2, SIAM-III). But in our country not all centers for treatment of MI are equipped by catheterization laboratory. That is why thrombolytic therapy (TLT) remains actual till today. In any type of treatment tactic in postinfarction heart would be seen remodeling processes with involvement to the pathological process of extracellular morphologic substrate. Pathological changes of extracellular matrix lead to increases of myocardium stiffness and reconstruction of heart chambers geometry. It leads to transformation of spatial organization of heart chambers, violation of blood filling and ejection and formation of systolic and diastolic dysfunction. The synthesis and degradation of extracellular substance is controlled by systems MMP/TIMP, the ratio of which influence on the character of extracellular matrix of myocardium restructuring. Till today influence of TLT on the state of MMP/TIMP system and postinfarction remodeling formation still is not clarified.
The purpose of the study - to investigate the influence of thrombolytic therapy on condition of system of matrix metalloproteinase (MMP-9) and its inhibitors (TIMP-1), the status of intracardiac hemodynamics, frequency of acute postinfarction left ventricular aneurysm development in patients with Q-wave myocardial infarction.
Patients and methods. 116 patients with a diagnosis of acute Q-wave MI of anterior wall of the left ventricle (LV) were examined. Patients, admitted before 12 hours from the beginning of MI and who had no contraindications, received TLT using streptokinase and basic therapy. Patients, admitted later than 12 hours from the beginning of MI or who had contraindications, received basic therapy only, which included statins, anticoagulants, antiplatelet agents, beta-blockers, ACE inhibitors, nitrates by demand. Depending on the implementation of TLT all patients were divided into next groups: the 1st – 74 patients who received TLT, the 2nd - 42 patients, who were treated without TLT. All patients were examined by clinical, laboratory and EchoCG methods on the fifth day. Serum levels of matrix metalloproteinases-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) were determined.
Results and discussion. Analysis of indicators which characterize the MMP/TIMP system showed the lower level of MMP-9 in patients of the first group. Serum level of TIMP-1 in the first group was higher in comparison with patients of the second group.
During EchoCG in patients of the second group higher than in the first group indexes of end-diastolic diameter of LV, end-systolic diameter of LV, LV myocardial mass index, stroke volume, stroke index, cardiac output, velocity of early diastolic filling of LV, the ratio of the velocity of early diastolic filling and late diastolic filling of LV, average pressure in pulmonic artery, the frequency of left ventricular aneurysm detection and the phenomenon of spontaneous ventricular contrasting were found. Such indexes as ejection fraction, atrial systole flow velocity, deceleration time of early diastolic filling flow and isovolumic relaxation time of LV were lower than in the first group.
Conclusions
- Excessive activation of proteolysis system on the background of relative deficit of TIMP-1was revealed in patients with Q-wave MI, who were treated without TLT.
- Treatment of patients with Q-wave MI with basic therapy only, lead to the LV remodeling, to dilation way predominantly.
- Violation of diastolic function of LV was typical for all patients with Q-wave MI, but absence of TLT changes it from impaired relaxation to the restrictive type.
- In patients with Q-wave MI without usage of TLT more frequently aneurysm of LV and the phenomenon of spontaneous ventricular contrast were revealed, that confirms the high thrombogenic potential.
- Correlation analysis demonstrated close relationship between main regulators of extracellular matrix condition and indicators of postinfarction remodeling process.
References
Berezin, A. E., & Samura, T. A. (2011) Prognosticheskij potencial markerov biomekhanicheskogo stressa u pacientov, perenesshikh Q-infarkt miokarda. Rezul'taty prospektivnogo odnogodichnogo issledovanija [Prognostic value of biochemical stress markers in patients with Q-myocardial infarction. Results of prospective study]. Ukrainskyi medychnyi chasopys, 6(86), 100–103. [in Ukrainian].
Dzyak, G. V., Koval`, E. A., Ivanov, A. P., & Shevcova, A. I. (2005) Tip degradacii fibronektina kak novyj dopolnitel'nyj faktor riska tromboticheskikh i gemorragicheskikh oslozhnenij ostrogo infarkta miokarda s zubcom Q [Type of fibronectin degradation as new additional risk factor of thrombotic and hemorrhagic complications of acute Q-wave myocardial infarction]. Serce i sudyny, 1(17), 13–18. [in Ukrainian].
Kalinkin, M. N., Solovjov, V. A., Shinkarenko, T. V., Egorova, E. N., Masur, E. S. (2011) Matriksnye metalloproteinazy i ikh rol' v patogeneze serdechno-sosudistykh zabolevanij [Matrix metalloproteinases and their role in pathogenesis of cardio-vascular diseases]. Vestnik TvGU. Seriya «Biologiya i ekologiya», 12(22), 64–76. [in Russian].
Celujko, V. I., Losovaya, T. A., Knysh, D. A., & Dernovaya, O. V. (2012) Osobennosti pokazatelej gemodinamiki i diastolicheskoj funkcii u bol'nykh s infarktom miokarda zadnej stenki levogo zheludochka s vovlecheniem pravogo zheludochka [Peculiarities of hemodynamic and diastolic function indexes in patients with myocardial infarction of posterior wall of left ventricle with involvement of right ventricle]. Ukrinskyi kardiologichnyi zhurnal, 6, 35–43. [in Ukrainian].
Goncharova, N. S., Moiseeva, O. M., Shlyakhlo, E. V. & Aleshina, G. M. (2007) Matriksnye metalloproteinazy: znachenie v remodelirovanii miokarda pri klapannykh porokakh serdca [Matrix metalloproteinases: signification in myocardium remodeling in valvular heart defects]. Kardiologiya, 12, 49–52. [in Russian].
(2013) ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 2013. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127, e362-e425. doi: 10.1161/CIR.0b013e3182742cf6.
Blankenberg, S. Rupprecht, HJ., Poirier, O., et al. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease. Circulation, 107, 1579–85.
Ferroni, P., Basili, S., Martini F., et al. (2003) Serum metalloproteinase-9 levels in patients with coronary artery disease: a novel marker of inflammation. J Investig Med, 51, 295–300.
Grines, CL, & Serruys, P. (2003) O'Neill WW: Fibrinolytic therapy: Is it a treatment of the past? Circulation, 107, 2538. doi: 10.1161/01.CIR.0000075292.29458.BB.
Kai, H., Ikeda, H., Yasukawa, H., et al. (1998) Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol, 32, 368–72.
Mickleborough, L. L., Carson, S., & Ivanov, J. (2001) Repair of dyskinetic or akinetic left ventricular aneurysm: results obtained with a modified linearclosure. J. Thorac. Cardiovasc. Surg, 121, 675–682. doi: 10.1067/mtc.2001.112633.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
